Xiao Han

机构：Tianjin University of Traditional Chinese Medicine, University of Science and Technology of China, Nantong University, Nankai University, Guangzhou Women and Children Medical Center, Guangzhou Medical University · ORCID：0000-0002-3295-6213

发表论文 154 篇 · 总被引 8283 次 · h-index 46

代表论文

• Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial (2024 · Signal Transduction and Targeted Therapy · 被引 30)
• Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis (2023 · Frontiers in Oncology · 被引 14)
• CD133-Targeted Hybrid Nanovesicles for Fluorescent/Ultrasonic Imaging-Guided HIFU Pancreatic Cancer Therapy (2023 · International Journal of Nanomedicine · 被引 14)
• Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images (2024 · Pathology · 被引 9)
• TRIM38 Induced in Respiratory Syncytial Virus-infected Cells Downregulates Type I Interferon Expression by Competing with TRIM25 to Bind RIG-I (2024 · Inflammation · 被引 8)
• GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway (2025 · Scientific Reports · 被引 4)